FGEN
FibroGen Inc
Company Overview
| Mkt Cap | $43.71M | Price | $11.12 |
| Volume | 16.42K | Change | +0.72% |
| P/E Ratio | -0.9 | Open | $11.13 |
| Revenue | $29.6M | Prev Close | $11.04 |
| Net Income | $-47.6M | 52W Range | $4.50 - $21.95 |
| Div Yield | N/A | Target | $43.00 |
| Overall | 44 | Value | 40 |
| Quality | 34 | Technical | 60 |
No chart data available
Stock Overview
Updated DailyFibroGen Inc (FGEN) is a leading Healthcare company in the Biotechnology industry, currently trading at $11.12 with a market capitalization of $43.71 million. The stock is in the lower portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 34.
Today's trading session shows FGEN with a volume of 16K shares. The stock opened up 0.82% from yesterday's close of $11.04. Current analyst estimates project earnings of $-10.84 per share for this year, with next year targeting $-15.11.
FGEN demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including ILMN, A, HBIO, PACB.
Key investment considerations for FGEN include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 286.7%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 08:37 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FGEN | $11.12 | +0.7% | 16.42K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |